State of Wisconsin Investment Board’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Buy
51,022
+12,103
+31% +$313K ﹤0.01% 1590
2025
Q4
$989K Sell
38,919
-12,323
-24% -$275K ﹤0.01% 1688
2025
Q3
$826K Sell
51,242
-42,651
-45% -$690K ﹤0.01% 1684
2025
Q2
$1.5M Buy
93,893
+38,180
+69% +$577K ﹤0.01% 1421
2025
Q1
$952K Buy
55,713
+13,539
+32% +$283K ﹤0.01% 1505
2024
Q4
$1.04M Sell
42,174
-26,419
-39% -$749K ﹤0.01% 1509
2024
Q3
$1.96M Sell
68,593
-3,152
-4% -$93K ﹤0.01% 1315
2024
Q2
$1.89M Buy
71,745
+20,344
+40% +$579K 0.01% 1310
2024
Q1
$1.66M Sell
51,401
-1,422
-3% -$51.9K ﹤0.01% 1298
2023
Q4
$2.23M Sell
52,823
-6,363
-11% -$234K 0.01% 1215
2023
Q3
$2.27M Sell
59,186
-11,030
-16% -$249K 0.01% 1220
2023
Q2
$1.33M Buy
70,216
+34,432
+96% +$642K ﹤0.01% 1391
2023
Q1
$555K Sell
35,784
-11,445
-24% -$199K ﹤0.01% 1827
2022
Q4
$838K Sell
47,229
-164,416
-78% -$2.07M ﹤0.01% 1591
2022
Q3
$1.18M Sell
211,645
-13,122
-6% -$64.1K ﹤0.01% 1478
2022
Q2
$877K Buy
224,767
+87,667
+64% +$379K ﹤0.01% 1718
2022
Q1
$755K Buy
137,100
+87,800
+178% +$547K ﹤0.01% 1702
2021
Q4
$420K Hold
49,300
﹤0.01% 1731
2021
Q3
$428K Hold
49,300
﹤0.01% 1735
2021
Q2
$521K Hold
49,300
﹤0.01% 1677
2021
Q1
$791K Hold
49,300
﹤0.01% 1433
2020
Q4
$2.28M Buy
49,300
+18,600
+61% +$860K 0.01% 1179
2020
Q3
$1.08M Buy
+30,700
New +$923K ﹤0.01% 1272

Other funds holding IMVT

State of Wisconsin Investment Board's IMVT Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Immunovant (IMVT) stake by 31% in Q1 2026, buying an estimated $313K and bringing the position to 51,022 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1590.

State of Wisconsin Investment Board first reported a position in IMVT in Q3 2020 and has held it in 23 quarters since. The position peaked at $2.28M in Q4 2020. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • State of Wisconsin Investment Board held 51,022 shares of Immunovant worth $1.27M as of Q1 2026.
  • State of Wisconsin Investment Board bought 12,103 Immunovant shares in Q1 2026, an estimated $313K.
  • Immunovant made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1590 holding.
  • State of Wisconsin Investment Board first reported a position in Immunovant in Q3 2020 and has held it in 23 quarters since.
  • State of Wisconsin Investment Board's Immunovant position peaked at $2.28M in Q4 2020.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.